Annual CFF
$2.50 M
+$2.50 M+100.00%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual cash flow from financing activities is $2.50 million, with the most recent change of +$2.50 million (+100.00%) on December 31, 2023.
- During the last 3 years, GYRE annual CFF has risen by +$9.33 million (+136.63%).
- GYRE annual CFF is now at all-time high.
Performance
GYRE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$324.00 K
+$168.00 K+107.69%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly cash flow from financing activities is $324.00 thousand, with the most recent change of +$168.00 thousand (+107.69%) on September 30, 2024.
- Over the past year, GYRE quarterly CFF has dropped by -$2.18 million (-87.04%).
- GYRE quarterly CFF is now -87.04% below its all-time high of $2.50 million, reached on December 31, 2023.
Performance
GYRE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$3.64 M
+$324.00 K+9.78%
September 30, 2024
Summary
- As of February 7, 2025, GYRE TTM cash flow from financing activities is $3.64 million, with the most recent change of +$324.00 thousand (+9.78%) on September 30, 2024.
- Over the past year, GYRE TTM CFF has increased by +$1.14 million (+45.52%).
- GYRE TTM CFF is now at all-time high.
Performance
GYRE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GYRE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | -87.0% | +45.5% |
| 3 y3 years | +136.6% | +100.0% | +100.0% |
| 5 y5 years | +136.6% | +100.0% | +100.0% |
GYRE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +136.6% | -87.0% | +353.3% | at high | +2944.4% |
| 5 y | 5-year | at high | +136.6% | -87.0% | +353.3% | at high | +2944.4% |
| alltime | all time | at high | +136.6% | -87.0% | +353.3% | at high | +2944.4% |
Gyre Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $324.00 K(+107.7%) | $3.64 M(+9.8%) |
| Jun 2024 | - | $156.00 K(-76.3%) | $3.31 M(+4.9%) |
| Mar 2024 | - | $658.00 K(-73.7%) | $3.16 M(+26.3%) |
| Dec 2023 | $2.50 M | $2.50 M(>+9900.0%) | $2.50 M(>+9900.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2022 | $0.00(-100.0%) | - | - |
| Mar 2022 | - | -$127.90 K | -$127.90 K |
| Dec 2021 | -$6.83 M | - | - |
FAQ
- What is Gyre Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Gyre Therapeutics?
- What is Gyre Therapeutics annual CFF year-on-year change?
- What is Gyre Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly CFF year-on-year change?
- What is Gyre Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Gyre Therapeutics?
- What is Gyre Therapeutics TTM CFF year-on-year change?
What is Gyre Therapeutics annual cash flow from financing activities?
The current annual CFF of GYRE is $2.50 M
What is the all time high annual CFF for Gyre Therapeutics?
Gyre Therapeutics all-time high annual cash flow from financing activities is $2.50 M
What is Gyre Therapeutics annual CFF year-on-year change?
Over the past year, GYRE annual cash flow from financing activities has changed by +$2.50 M (+100.00%)
What is Gyre Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of GYRE is $324.00 K
What is the all time high quarterly CFF for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly cash flow from financing activities is $2.50 M
What is Gyre Therapeutics quarterly CFF year-on-year change?
Over the past year, GYRE quarterly cash flow from financing activities has changed by -$2.18 M (-87.04%)
What is Gyre Therapeutics TTM cash flow from financing activities?
The current TTM CFF of GYRE is $3.64 M
What is the all time high TTM CFF for Gyre Therapeutics?
Gyre Therapeutics all-time high TTM cash flow from financing activities is $3.64 M
What is Gyre Therapeutics TTM CFF year-on-year change?
Over the past year, GYRE TTM cash flow from financing activities has changed by +$1.14 M (+45.52%)